Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose

Nutrition Journal

Volumn 8, Issue 1, 2009, Pages

  Maki, Kevin C ^a   McKenney, James M ^b   Farmer, Mildred V ^c   Reeves, Matthew S ^a   Dicklin, Mary R ^a  

^a Provident Clinical Research   (United States)

^b National Clinical Research Inc   (United States)

^c Meridien Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; TEST MEAL; AREA UNDER THE CURVE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; METABOLISM; METHODOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SECRETION;

AREA UNDER CURVE; BLOOD GLUCOSE; C-PEPTIDE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 67649404863     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-8-22     Document Type: Article

References (29)

1. Obesity, body fat distribution, insulin sensitivity and islet beta-cell function as explanations for metabolic diversity. SE Kahn RL Prigeon RS Schwartz, J Nutr 2001 131 354S 360S 11160560
2. Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. D Porte Jr SE Kahn, Diabetes 2001 50 Suppl 1 S160 S163 10.2337/diabetes.50.2007.S160 11272181
3. Contribution of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. MA Abdul-Ghani D Tripathy RA DeFronzo, Diabetes Care 2006 29 1130 1139 10.2337/dc05-2179 16644654
4. Insulin sensitivity indices obtained from oral glucose tolerance testing. M Matsuda RA DeFronzo, Diabetes Care 1999 22 1462 1470 10.2337/diacare.22.9. 1462 10480510
5. Evaluation of insulin sensitivity in clinical practice and in research settings. LU Monzillo O Hamdy, Nutr Rev 2003 61 397 412 10.1301/nr.2003.dec.397- 412 14968910
6. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. R Muniyappa S Lee H Chen MJ Quon, Am J Physiol Endocrinol Metab 2008 294 E15 E26 10.1152/ajpendo.00645. 2007 17957034
7. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. R Retnakaran S Shen AJ Hanley V Vuksan JK Hamilton B Zinman, Obesity 2008 16 1901 1907 10.1038/oby.2008.307 18551118
8. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. SE Kahn RL Prigeon DK McCulloch, Diabetes 1993 42 1663 1672 10.2337/diabetes.42.11. 1663 8405710
9. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. SE Kahn, Diabetologia 2003 46 3 19 10.1007/s00125-003-1190-9 12637977
10. Gut hormones and appetite control. AM Wren SR Bloom, Gastroenterology 2007 132 2116 2130 10.1053/j.gastro.2007.03.048 17498507
11. Incretin-based therapies in type 2 diabetes mellitus. CW Chia JM Egan, J Clin Endocrinol Metab 2008 10 3703 3716 10.1210/jc.2007-2109
12. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. K Vollmer JJ Holst B Baller, Diabetes 2008 57 678 687 10.2337/db07-1124 18057091
13. Evaluation of insulin sensitivity and glucose effectiveness during a standardized breakfast test: comparison with the minimal model analysis of an intravenous glucose tolerance test. I Aloulou JF Brun J Mercier, Metabolism 2006 55 676 690 10.1016/j.metabol.2006.01.002 16631446
14. Insulin sensitivity from meal tolerance tests in normal subjects: A minimal model index. A Caumo RN Bergman C Cobelli, J Clin Endocrinol Metab 2000 85 4396 4402 10.1210/jc.85.11.4396 11095485
15. Beta-cell response during a meal test. LS Cozma SD Luzio GJ Dunseath PM Underwood DR Owens, Diab Care 2005 28 1001 1007 10.2337/diacare.28.5.1001
16. Two-hour seven-sample oral glucose tolerance test and meal protocol. Minimal model assessment of b-cell responsivity and insulin sensitivity in non-diabetic individuals. C Dalla Man M Campioni KS Polonsky, Diabetes 2005 54 3265 3273 10.2337/diabetes.54.11.3265 16249454
17. Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. MD Robertson JM Currie LM Morgan DP Jewell KN Frayn, Diabetologia 2003 46 659 665 12712245
18. Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test. GM Steil C Hwu R Janowski, Diabetes 2004 53 1201 1207 10.2337/diabetes.53.5.1201 15111487
19. A new method for the continuous monitoring of blood glucose by measurement of dissolved oxygen. AH Kadish DA Hall, Clin Chem 1965 11 869 875 5835655
20. Immunoanalysis of human insulin using monoclonal antibodies reveals antigenicity of evolutionarily conserved residues. SM Allauzen S Joly C Granier, Mol Immunol 1995 32 27 36 10.1016/0161-5890(94)00133-L 7870056
21. C-peptide suppression test: effects of gender, age, and body mass index; implications for the diagnosis of insulinoma. FJ Service PC O'Brien PC Kao WF Young Jr, J Clin Endocrinol Metab 1992 74 204 210 10.1210/jc.74.1.204 1727822
22. Glycaemic index methodology. F Brouns I Bjorck KN Frayn, Nutr Res Rev 2005 18 145 171 10.1079/NRR2005100 19079901
23. Standards of medical care in diabetes 2007. American Diabetes Association, Diabetes Care 2007 30 Suppl 1 S4 S41 10.2337/dc07-S004 17192377
24. Efficacy and safety of combination therapy. Repaglinide plus metformin versus nateglinide plus metformin. P Raskin L Klaff J McGill, Diab Care 2003 26 2063 2068 10.2337/diacare.26.7.2063
25. Use and abuse of HOMA modeling. TM Wallace JC Levy DR Mathews, Diabetes Care 2004 27 1487 1495 10.2337/diacare.27.6.1487 15161807
26. -cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes. Comparison of surrogate markers of first-phase insulin secretion from an intravenous glucose tolerance test. A Festa K Williams AJG Hanley SM Haffner, Diabetes 2008 57 1638 1644 10.2337/db07-0954 18332099
27. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. MA Abdul-Ghani B Balas M Matsuda RA DeFronzo, Diabetes Care 2007 30 89 94 10.2337/dc06-1519 17192339
28. Impaired fasting glycaemic vs. impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. K Faerch A Vaag JJ Holst C Glumer O Pedersen K Borch-Johnsen, Diabetologia 2008 51 853 861 10.1007/s00125-008-0951-x 18317726
29. Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes? L Perreault BC Bergman MC Playdon C Dalla Man C Cobelli RH Eckel, Am J Physiol Endocrinol Metab 2008 295 E428 E435 10.1152/ajpendo.90354.2008 18523123